People diagnosed with lung cancer may benefit from a newly launched campaign to match lung cancer patients with current clinical trials based on their individual situations.
The Lung Cancer Clinical Trial Call to Action campaign offers easy-to-use educational and trial-matching resources to help identify clinical trials that are appropriate to each patient’s diagnosis, stage and treatment history.
The campaign is a collaboration of six leading patient advocacy organizations, including CancerCare’s lungcancer.org, a leading resource for people affected by lung cancer.
Patients can access the Lung Cancer Clinical Trial Matching Service online by visiting www.lungcancer.org or by calling 1-800-698-0931, to speak directly with a clinical trial specialist who can guide them through the entire process.
Other organizations in the campaign include the Lung Cancer Alliance, Uniting Against Lung Cancer, National Lung Cancer Partnership, LUNGevity and the Respiratory Health Association of Metropolitan Chicago. EmergingMed is the service provider for the Lung Cancer Clinical Trials Matching Service.
The effort is being supported by several major pharmaceutical companies dedicated to the fight against lung cancer, including Boehringer Ingelheim Pharmaceuticals, Inc., Amgen Inc., AstraZeneca, Genentech BioOncology, and Pfizer Oncology.
